'Biological Experiments' By China On PLA's Han Soldiers Risk To India, Warns Ex-Indian Colonel
A gene research program being jointly undertaken by Chinese company BGI Group
and the People’s Liberation Army (PLA) has direct security implications for
India, a retired Indian Army Colonel and a defence analyst Jaibans Singh has
warned.
UK-based Reuters agency reported on 7 July that BGI Group has published
studies on interactions between genes and drugs to protect "Han" soldiers
stationed at high-altitude regions from "brain surgeries". These studies
“refer to soldiers stationed in Tibet and Xinjiang, high plateau regions which
border India’s Ladakh, where fighting broke out last June," as per the news
agency.
“Ever since the Galwan clash and build-up of eyeball-to-eyeball contact along
the Line of Actual Control the Chinese military machinery has been in a state
of frenzy. There is a growing sense of realization that it is ill-prepared to
meet the Indian challenge in conventional operations at high altitude,”
Colonel Jaibans Singh (Retd) tells Sputnik.
Singh, who has served at the China border during his tenure, adds that the PLA
has always been “uncomfortable” with the idea of high-altitude warfare, as
most of Chinese population is concentrated along the country’s eastern
seaboard.
“Long presence in such high altitude is not something that the Chinese troops
can sustain, hence the need to build upon their physical capacity. I believe
all such biological experiments are directed toward that desired end state,”
explains the Indian defence veteran.
Twenty Indian soldiers and 4 PLA troops were killed when both armies clashed
at the Galwan Valley, one of the friction points at the 3488-km Line of Actual
Control- a loosely demarcated border between India and China. Indian Army and
the PLA have been embroiled in more than an year-old military standoff in the
eastern Ladakh region.
In a bid to end the standoff, India and China have so far held 11 rounds of
military commander-level talks, during which they decided to mutually
disengage troops from forward positions.
As part of the ongoing disengagement process, troops on both sides have
retreated from one friction point on the northern bank of Pangong Tso Lake,
while China has reportedly pulled back troops from forward positions in the
Galwan Valley.
However, the PLA is yet to remove troops from Gogra Post, Hot Springs, and
Depsang, the other points of contention in the ongoing dispute, even as both
the armies have mobilized hundreds of thousands of soldiers and advanced
military equipment at the border.
Gene Research A ‘National Security Threat’, Says US
The US government advisors reportedly red-flagged the research in March this
year, with the US National Security Commission on Artificial Intelligence
(NSCAI) warning that the study could pose as a national security threat to
Washington as it could give Beijing a “strategic edge” over other nations.
— Solomon Yue (@SolomonYue) July 9, 2021
"BGI published studies w/ the 3rd Military Medical University in Chongqing exploring whether drugs interacting w/ genes could protect Han Chinese, the country’s majority ethnic group, from brain injury at high altitudes." I'm adding "against #India army" https://t.co/e6WR8j3mn4 https://t.co/jfpFh2oxO6
— Solomon Yue (@SolomonYue) July 9, 2021
More than 8 million women are said to have taken the prenatal test till now.
The BGI Group has reportedly claimed that it has the “location data” of only
the women in China. The company has also denied sharing the data with the
Chinese government, though it has admitted that such data could be supplied to
the authorities if requested on grounds of national security.
The study on improving the high-altitude effectiveness of Han Chinese troops
is among a dozen of studies published by the company in collaboration with the
PLA.
The Chinese foreign ministry has rejected the allegations levelled in the
Reuters news article.
No comments:
Post a Comment